Compass Ion Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Compass Ion Advisors's AMGN Position: Q2 2026 in Review
Compass Ion Advisors increased its Amgen (AMGN) stake by 0.2% in Q2 2026, buying an estimated $3.77K and bringing the position to 5,577 shares worth $2.02M. The position accounts for 0.17% of the portfolio, ranked #70.
Compass Ion Advisors first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Compass Ion Advisors held 5,577 shares of Amgen worth $2.02M as of Q2 2026.
- Compass Ion Advisors bought 11 Amgen shares in Q2 2026, an estimated $3.77K.
- Amgen made up 0.17% of Compass Ion Advisors's portfolio in Q2 2026, its #70 holding.
- Compass Ion Advisors first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.